Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study.

[1]  E. Solary,et al.  Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review. , 2019, Autoimmunity reviews.

[2]  P. Fenaux,et al.  Autoimmune manifestations associated with myelodysplastic syndromes , 2018, Annals of Hematology.

[3]  Mayumi Tanaka,et al.  Successful Treatment of Behçet's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation , 2017, Internal medicine.

[4]  O. Decaux,et al.  Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: A series of 26 cases and literature review. , 2016, Leukemia research.

[5]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[6]  O. Decaux,et al.  Efficacy of Azacitidine in Autoimmune and Inflammatory Disorders associated with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Running title : Azacitidine in autoimmune disorders associated with MDS / CMML , 2018 .

[7]  J. Piette,et al.  Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. , 2016, Rheumatology.

[8]  P. Fenaux,et al.  Myelodysplastic syndromes , 2014, The Lancet.

[9]  栄一 末松.  血管炎の新分類2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides , 2013 .

[10]  D. Henrion,et al.  Prognosis of vasculitis associated myelodysplasia. , 2013, Autoimmunity reviews.

[11]  S. Sait,et al.  Myelodysplastic syndromes and autoimmune diseases--case series and review of literature. , 2013, Leukemia research.

[12]  J. Valeriano-Marcet,et al.  Myelodysplasia and Malignancy-Associated Vasculitis , 2012, Current Rheumatology Reports.

[13]  S. Fleming,et al.  Paraneoplastic large vessel arteritis complicating myelodysplastic syndrome , 2012, Leukemia & lymphoma.

[14]  D. Henrion,et al.  Systemic and immune manifestations in myelodysplasia: A multicenter retrospective study , 2011, Arthritis care & research.

[15]  Sophie Park,et al.  The autoimmune manifestations associated with myelodysplastic syndrome respond to 5‐azacytidine: a report on three cases , 2011, British journal of haematology.

[16]  J. Piette,et al.  Vasculitides associated with malignancies: analysis of sixty patients. , 2007, Arthritis and rheumatism.

[17]  H. Raspe,et al.  EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis , 2006, Annals of the rheumatic diseases.

[18]  D. Farmakis,et al.  Myelodysplastic syndrome associated with multiple autoimmune disorders , 2005, Clinical Rheumatology.

[19]  F. Strutz,et al.  Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  M. Hamidou,et al.  Systemic medium-sized vessel vasculitis associated with chronic myelomonocytic leukemia. , 2001, Seminars in arthritis and rheumatism.

[21]  G. Vercellotti,et al.  Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy , 1995, British journal of haematology.

[22]  B. Johansson,et al.  Immune‐mediated complications in patients with myelodysplastic syndromes – clinical and cytogenetic features , 1995, European journal of haematology.